XML 75 R55.htm IDEA: XBRL DOCUMENT v3.3.1.900
GUARANTOR AND NON-GUARANTOR FINANCIAL INFORMATION (Tables)
12 Months Ended
Dec. 31, 2015
Guarantor and Non-Guarantor Financial Information [Abstract]  
Schedule of Condensed Balance Sheet [Table Text Block]
The following tables present condensed consolidating financial information relating to the Guarantor Subsidiaries as at December 31, 2015 and 2014, and for the years ended December 31, 2015, 2014 and 2013:
Condensed Consolidating Balance Sheets as at December 31, 2015
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

ASSETS
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
9,273

 
$
118

 
$
52,288

 
$

 
$
61,679

Accounts receivable, net

 

 
167,427

 

 
167,427

Program rights, net

 

 
85,972

 

 
85,972

Other current assets
681

 
1,680

 
40,845

 

 
43,206

Intercompany current assets
10,612

 
1,788

 
27,300

 
(39,700
)
 

Total current assets
20,566

 
3,586

 
373,832

 
(39,700
)
 
358,284

Non-current assets
 
 
 
 
 
 
 
 
 
Investments in subsidiaries
204,531

 
1,266,585

 

 
(1,471,116
)
 

Property, plant and equipment, net

 

 
108,522

 

 
108,522

Program rights, net

 

 
169,073

 

 
169,073

Goodwill

 

 
622,243

 

 
622,243

Broadcast licenses and other intangible assets, net

 

 
151,162

 

 
151,162

Other non-current assets
40,844

 
2,445

 
1,628

 

 
44,917

Intercompany non-current assets
1,055,286

 
34,894

 
558,518

 
(1,648,698
)
 

Total non-current assets
1,300,661

 
1,303,924

 
1,611,146

 
(3,119,814
)
 
1,095,917

Total assets
$
1,321,227

 
$
1,307,510

 
$
1,984,978

 
$
(3,159,514
)
 
$
1,454,201

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
$
2,622

 
$
242

 
$
131,841

 
$

 
$
134,705

Current portion of long-term debt and other financing arrangements

 

 
1,155

 

 
1,155

Other current liabilities
650

 
247

 
9,551

 

 
10,448

Intercompany current liabilities
5,194

 
31,635

 
2,871

 
(39,700
)
 

Total current liabilities
8,466

 
32,124

 
145,418

 
(39,700
)
 
146,308

Non-current liabilities
 

 
 

 
 
 
 
 
 
Long-term debt and other financing arrangements
919,812

 

 
2,493

 

 
922,305

Other non-current liabilities
39,596

 

 
26,153

 

 
65,749

Intercompany non-current liabilities
34,895

 
1,194,226

 
419,577

 
(1,648,698
)
 

Total non-current liabilities
994,303

 
1,194,226

 
448,223

 
(1,648,698
)
 
988,054

Temporary equity
241,198

 

 

 

 
241,198

Total CME Ltd. shareholders’ equity
77,260

 
81,160

 
1,389,956

 
(1,471,116
)
 
77,260

Noncontrolling interests

 

 
1,381

 

 
1,381

Total equity
77,260

 
81,160

 
1,391,337

 
(1,471,116
)
 
78,641

Total liabilities and equity
$
1,321,227

 
$
1,307,510

 
$
1,984,978

 
$
(3,159,514
)
 
$
1,454,201

Condensed Consolidating Balance Sheets as at December 31, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

ASSETS
 
 
 
 
 
 
 
 
 
Current assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
613

 
$
2,931

 
$
30,754

 
$

 
$
34,298

Accounts receivable, net

 

 
175,866

 

 
175,866

Program rights, net

 

 
99,358

 

 
99,358

Other current assets
1,007

 
346

 
34,128

 

 
35,481

Assets held for sale

 

 
29,866

 

 
29,866

Intercompany current assets
12,582

 
14,333

 
17,492

 
(44,407
)
 

Total current assets
14,202

 
17,610

 
387,464

 
(44,407
)
 
374,869

Non-current assets
 

 
 

 
 
 
 
 
 
Investments in subsidiaries
110,186

 
1,516,707

 

 
(1,626,893
)
 

Property, plant and equipment, net

 

 
114,335

 

 
114,335

Program rights, net

 

 
207,264

 

 
207,264

Goodwill

 

 
681,398

 

 
681,398

Broadcast licenses and other intangible assets, net

 

 
183,378

 

 
183,378

Other non-current assets
55,471

 

 
2,645

 

 
58,116

Intercompany non-current assets
1,252,708

 
32,781

 
291,589

 
(1,577,078
)
 

Total non-current assets
1,418,365

 
1,549,488

 
1,480,609

 
(3,203,971
)
 
1,244,491

Total assets
$
1,432,567

 
$
1,567,098

 
$
1,868,073

 
$
(3,248,378
)
 
$
1,619,360

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities
 
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
$
5,109

 
$
286

 
$
173,829

 
$

 
$
179,224

Current portion of long-term debt and other financing arrangements
251,669

 

 
1,190

 

 
252,859

Other current liabilities
271

 

 
7,541

 

 
7,812

Liabilities held for sale

 

 
10,632

 

 
10,632

Intercompany current liabilities
7,003

 
35,151

 
2,253

 
(44,407
)


Total current liabilities
264,052

 
35,437

 
195,445

 
(44,407
)
 
450,527

Non-current liabilities
 

 
 

 
 
 
 
 
 
Long-term debt and other financing arrangements
615,698

 

 
5,542

 

 
621,240

Other non-current liabilities
16,315

 
482

 
29,688

 

 
46,485

Intercompany non-current liabilities
32,782

 
1,392,535

 
151,761

 
(1,577,078
)
 

Total non-current liabilities
664,795

 
1,393,017

 
186,991

 
(1,577,078
)
 
667,725

Temporary equity
223,926

 

 

 

 
223,926

Total CME Ltd. shareholders’ equity
279,794

 
138,644

 
1,488,249

 
(1,626,893
)
 
279,794

Noncontrolling interests

 

 
(2,612
)
 

 
(2,612
)
Total equity
279,794

 
138,644

 
1,485,637

 
(1,626,893
)
 
277,182

Total liabilities and equity
$
1,432,567

 
$
1,567,098

 
$
1,868,073

 
$
(3,248,378
)
 
$
1,619,360

Schedule of Condensed Income Statement [Table Text Block]
Condensed Consolidating Statements of Operations and Comprehensive Income for the year ended December 31, 2015
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
605,841

 
$

 
$
605,841

Cost of revenues

 

 
402,543

 

 
402,543

Selling, general and administrative expenses
18,916

 
485

 
87,600

 

 
107,001

Restructuring costs

 

 
1,714

 

 
1,714

Operating (loss) / income
(18,916
)
 
(485
)
 
113,984

 

 
94,583

Interest expense
(174,257
)
 
(106,821
)
 
(15,307
)
 
124,941

 
(171,444
)
Non-operating income / (expense), net
97,480

 
(19,627
)
 
21,149

 
(124,941
)
 
(25,939
)
(Loss) / income from continuing operations before tax and (loss) / income from investment in subsidiaries

(95,693
)
 
(126,933
)
 
119,826

 

 
(102,800
)
Credit / (provision) for income taxes

 
16,007

 
(15,492
)
 

 
515

(Loss) / income from continuing operations before (loss) / income from investment in subsidiaries
(95,693
)
 
(110,926
)
 
104,334

 

 
(102,285
)
(Loss) / income from investment in subsidiaries
(19,208
)
 
92,772

 

 
(73,564
)
 

(Loss) / income from continuing operations
(114,901
)
 
(18,154
)
 
104,334

 
(73,564
)
 
(102,285
)
Loss from discontinued operations, net of tax

 
(1,054
)
 
(12,233
)
 

 
(13,287
)
Net (loss) / income
(114,901
)
 
(19,208
)
 
92,101

 
(73,564
)
 
(115,572
)
Net loss attributable to noncontrolling interests

 

 
671

 

 
671

Net (loss) / income attributable to CME Ltd.
$
(114,901
)
 
$
(19,208
)
 
$
92,772

 
$
(73,564
)
 
$
(114,901
)
 
 
 
 
 
 
 
 
 
 
Net (loss) / income
$
(114,901
)
 
$
(19,208
)
 
$
92,101

 
$
(73,564
)
 
$
(115,572
)
Other comprehensive (loss) / income
(91,936
)
 
13,065

 
(139,966
)
 
128,284

 
(90,553
)
Comprehensive loss
(206,837
)
 
(6,143
)
 
(47,865
)
 
54,720

 
(206,125
)
Comprehensive income attributable to noncontrolling interests

 

 
(712
)
 

 
(712
)
Comprehensive loss attributable to CME Ltd.
$
(206,837
)
 
$
(6,143
)
 
$
(48,577
)
 
$
54,720

 
$
(206,837
)

Condensed Consolidating Statements of Operations and Comprehensive Income for the year ended December 31, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
680,793

 
$

 
$
680,793

Cost of revenues

 

 
489,041

 

 
489,041

Selling, general and administrative expenses
19,026

 
804

 
123,786

 

 
143,616

Restructuring costs

 

 
9,856

 

 
9,856

Operating (loss) / income
(19,026
)
 
(804
)
 
58,110

 

 
38,280

Interest expense
(138,480
)
 
(137,891
)
 
(31,226
)
 
165,592

 
(142,005
)
Loss on extinguishment of debt
(24,161
)
 

 
(15,042
)
 

 
(39,203
)
Non-operating income / (expense), net
144,257

 
21,778

 
(10,338
)
 
(165,592
)
 
(9,895
)
(Loss) / income from continuing operations before tax and loss from investment in subsidiaries
(37,410
)
 
(116,917
)
 
1,504

 

 
(152,823
)
Credit / (provision) for income taxes

 
12,170

 
(10,812
)
 

 
1,358

Loss from continuing operations before loss from investment in subsidiaries
(37,410
)
 
(104,747
)
 
(9,308
)
 

 
(151,465
)
Loss on investment in subsidiaries
(190,018
)
 
(85,271
)
 

 
275,289

 

Loss from continuing operations
(227,428
)
 
(190,018
)
 
(9,308
)
 
275,289

 
(151,465
)
Loss from discontinued operations, net of tax


 

 
(80,431
)
 

 
(80,431
)
Net loss
(227,428
)
 
(190,018
)
 
(89,739
)
 
275,289

 
(231,896
)
Net loss attributable to noncontrolling interests

 

 
4,468

 

 
4,468

Net loss attributable to CME Ltd.
$
(227,428
)
 
$
(190,018
)
 
$
(85,271
)
 
$
275,289

 
$
(227,428
)
 
 
 
 
 
 
 
 
 
 
Net loss
$
(227,428
)
 
$
(190,018
)
 
$
(89,739
)
 
$
275,289

 
$
(231,896
)
Other comprehensive loss
(157,780
)
 
(315,291
)
 
(150,841
)
 
467,095

 
(156,817
)
Comprehensive loss
(385,208
)
 
(505,309
)
 
(240,580
)
 
742,384

 
(388,713
)
Comprehensive loss attributable to noncontrolling interests

 

 
3,505

 

 
3,505

Comprehensive loss attributable to CME Ltd.
$
(385,208
)
 
$
(505,309
)
 
$
(237,075
)
 
$
742,384

 
$
(385,208
)

Condensed Consolidating Statements of Operations and Comprehensive Income for the year ended December 31, 2013
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net revenues
$

 
$

 
$
633,134

 
$

 
$
633,134

Cost of revenues

 

 
578,570

 

 
578,570

Selling, general and administrative expenses
33,905

 
5

 
102,483

 

 
136,393

Restructuring costs
2,422

 
24

 
16,066

 

 
18,512

Impairment charge

 

 
79,676

 

 
79,676

Operating loss
(36,327
)
 
(29
)
 
(143,661
)
 

 
(180,017
)
Interest expense
(88,102
)
 
(124,100
)
 
(43,537
)
 
144,030

 
(111,709
)
Loss on extinguishment of debt
(23,115
)
 

 

 

 
(23,115
)
Non-operating income / (expense), net
167,318

 
15,449

 
(18,323
)
 
(144,030
)
 
20,414

Income / (loss) from continuing operations before tax and loss from investment in subsidiaries
19,774

 
(108,680
)
 
(205,521
)
 

 
(294,427
)
Credit for income taxes

 
9,510

 
8,483

 

 
17,993

Income / (loss) from continuing operations before loss from investment in subsidiaries
19,774

 
(99,170
)
 
(197,038
)
 

 
(276,434
)
Loss on investment in subsidiaries
(297,425
)
 
(198,255
)
 

 
495,680

 

Loss from continuing operations
(277,651
)
 
(297,425
)
 
(197,038
)
 
495,680

 
(276,434
)
Loss from discontinued operations, net of tax


 

 
(5,099
)
 

 
(5,099
)
Net loss
(277,651
)
 
(297,425
)
 
(202,137
)
 
495,680

 
(281,533
)
Net loss attributable to noncontrolling interests

 

 
3,882

 

 
3,882

Net loss attributable to CME Ltd.
$
(277,651
)
 
$
(297,425
)
 
$
(198,255
)
 
$
495,680

 
$
(277,651
)
 
 
 
 
 
 
 
 
 
 
Net loss
$
(277,651
)
 
$
(297,425
)
 
$
(202,137
)
 
$
495,680

 
$
(281,533
)
Other comprehensive loss
(57,979
)
 
(74,385
)
 
(5,428
)
 
79,592

 
(58,200
)
Comprehensive loss
(335,630
)
 
(371,810
)
 
(207,565
)
 
575,272

 
(339,733
)
Comprehensive loss attributable to noncontrolling interests

 

 
4,103

 

 
4,103

Comprehensive loss attributable to CME Ltd.
$
(335,630
)
 
$
(371,810
)
 
$
(203,462
)
 
$
575,272

 
$
(335,630
)
Schedule of Condensed Cash Flow Statement [Table Text Block]
Condensed Consolidating Statements of Cash Flows for the year ended December 31, 2015
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net cash generated from / (used in) continuing operating activities
$
46,196

 
$
(84,922
)
 
$
130,622

 
$
(6,019
)
 
$
85,877

CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of property, plant and equipment

 

 
(33,517
)
 

 
(33,517
)
Disposal of property, plant and equipment

 

 
3,091

 

 
3,091

Intercompany investing receipts
380,319

 
110,377

 
7,780

 
(498,476
)
 

Intercompany investing payments
(396,003
)
 
(53,127
)
 
(303,763
)
 
752,893

 

Net cash (used in) / provided by continuing investing activities
$
(15,684
)
 
$
57,250

 
$
(326,409
)
 
$
254,417

 
$
(30,426
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Repayments of Senior Debt
(261,034
)
 

 

 

 
(261,034
)
Debt transactions costs
(1,541
)
 

 

 

 
(1,541
)
Issuance of Senior Debt
253,051

 

 

 

 
253,051

Payment of credit facilities and capital leases
(26,117
)
 

 
(1,248
)
 

 
(27,365
)
Settlement of forward currency swaps
7,983

 

 

 

 
7,983

Intercompany financing receipts
22,707

 
132,090

 
328,783

 
(483,580
)
 

Intercompany financing payments
(16,901
)
 
(108,093
)
 
(110,188
)
 
235,182

 

Net cash (used in) / provided by continuing financing activities
$
(21,852
)
 
$
23,997

 
$
217,347

 
$
(248,398
)
 
$
(28,906
)
 
 
 
 
 
 
 
 
 
 
Net cash used in discontinued operations - operating activities

 

 
(3,019
)
 

 
(3,019
)
Net cash provided by discontinued operations - investing activities

 
3,779

 
2,819

 

 
6,598

Net cash used in discontinued operations - financing activities

 

 
(76
)
 

 
(76
)
 
 
 
 
 
 
 
 
 
 
Impact of exchange rate fluctuations on cash and cash equivalents

 
(2,917
)
 
250

 

 
(2,667
)
Net increase / (decrease) in cash and cash equivalents
$
8,660

 
$
(2,813
)
 
$
21,534

 
$

 
$
27,381

CASH AND CASH EQUIVALENTS, beginning of period
613

 
2,931

 
30,754

 

 
34,298

CASH AND CASH EQUIVALENTS, end of period
$
9,273

 
$
118

 
$
52,288

 
$

 
$
61,679



Condensed Consolidating Statements of Cash Flows for the year ended December 31, 2014
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net cash generated from / (used in) continuing operating activities
$
67,171

 
$
(132,570
)
 
$
157

 
$

 
$
(65,242
)
CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 


Purchase of property, plant and equipment

 

 
(28,685
)
 

 
(28,685
)
Disposal of property, plant and equipment

 

 
137

 

 
137

Intercompany investing receipts
703,941

 
356,217

 

 
(1,060,158
)
 

Intercompany investing payments
(900,009
)
 
(418,504
)
 
(260,529
)
 
1,579,042

 

Net cash used in continuing investing activities
$
(196,068
)
 
$
(62,287
)
 
$
(289,077
)
 
$
518,884

 
$
(28,548
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Repayments of Senior Debt
(400,673
)
 

 
(312,246
)
 

 
(712,919
)
Debt transactions costs
(12,396
)
 

 
(1,810
)
 

 
(14,206
)
Issuance of Senior Debt
550,421

 

 

 

 
550,421

Proceeds from credit facilities
25,000

 

 

 

 
25,000

Payment of credit facilities and capital leases

 

 
(1,080
)
 

 
(1,080
)
Issuance of common stock
191,825

 

 

 

 
191,825

Other

 

 
(46
)
 

 
(46
)
Intercompany financing receipts

 
634,862


720,248


(1,355,110
)
 

Intercompany financing payments
(243,778
)
 
(443,412
)
 
(149,036
)
 
836,226

 

Net cash provided by continuing financing activities
$
110,399

 
$
191,450

 
$
256,030

 
$
(518,884
)
 
$
38,995

 
 
 
 
 
 
 
 
 
 
Net cash used in discontinued operations - operating activities

(350
)
 

 
(1,058
)
 

 
(1,408
)
Net cash used in discontinued operations - investing activities


 

 
(228
)
 

 
(228
)
Net cash used in discontinued operations - financing activities

 

 
(942
)
 

 
(942
)
 
 
 
 
 
 
 
 
 
 
Impact of exchange rate fluctuations on cash and cash equivalents

 
916

 
(11,567
)
 

 
(10,651
)
Net decrease in cash and cash equivalents
$
(18,848
)
 
$
(2,491
)
 
$
(46,685
)
 
$

 
$
(68,024
)
CASH AND CASH EQUIVALENTS, beginning of period
19,461

 
5,422

 
77,439

 

 
102,322

CASH AND CASH EQUIVALENTS, end of period
$
613

 
$
2,931

 
$
30,754

 
$

 
$
34,298


Condensed Consolidating Statements of Cash Flows for the year ended December 31, 2013
 
Parent Issuer

 
Guarantor Subsidiaries

 
Non-Guarantor Subsidiaries

 
Eliminations

 
Consolidated

Net cash (used in) / generated from continuing operating activities
$
(80,304
)
 
288,651

 
(269,417
)
 

 
(61,070
)
CASH FLOWS FROM INVESTING ACTIVITIES:
 
 
 
 
 
 
 
 
 
Purchase of property, plant and equipment

 

 
(30,118
)
 

 
(30,118
)
Disposal of property, plant and equipment

 

 
283

 

 
283

Intercompany investing receipts
609,801

 
9,323

 

 
(619,124
)
 

Intercompany investing payments
(580,533
)
 
(266,355
)
 

 
846,888

 

Net cash provided by / (used in) continuing investing activities
$
29,268

 
$
(257,032
)
 
$
(29,835
)
 
$
227,764

 
$
(29,835
)
 
 
 
 
 
 
 
 
 
 
CASH FLOWS FROM FINANCING ACTIVITIES:
 

 
 
 
 
 
 
 
 
Repayments of Senior Debt
(310,322
)
 

 

 

 
(310,322
)
Debt transactions costs
(785
)
 

 

 

 
(785
)
Change in restricted cash
20,467

 

 
138

 

 
20,605

Proceeds from credit facilities

 

 
40

 

 
40

Payment of credit facilities and capital leases

 

 
(1,648
)
 

 
(1,648
)
Issuance of common stock
157,116

 

 

 

 
157,116

Issuance of preferred stock
200,000

 

 

 

 
200,000

Equity issuance costs
(5,410
)
 

 

 

 
(5,410
)
Other
59

 

 
(411
)
 

 
(352
)
Intercompany financing receipts

 
580,533


266,355


(846,888
)
 

Intercompany financing payments

 
(609,801
)

(9,323
)

619,124

 

Net cash provided by / (used in) continuing financing activities
$
61,125

 
$
(29,268
)
 
$
255,151

 
$
(227,764
)
 
$
59,244

 
 
 
 
 
 
 
 
 
 
Net cash used in discontinued operations - operating activities

 

 
(1,952
)
 

 
(1,952
)
Net cash used in discontinued operations - investing activities


 

 
(301
)
 

 
(301
)
Net cash provided by discontinued operations - financing activities


 

 
77

 

 
77

 
 
 
 
 
 
 
 
 
 
Impact of exchange rate fluctuations on cash and cash equivalents

 
235

 
(619
)
 

 
(384
)
Net increase / (decrease) in cash and cash equivalents
$
10,089

 
$
2,586

 
$
(46,896
)
 
$

 
$
(34,221
)
CASH AND CASH EQUIVALENTS, beginning of period
9,372

 
2,836

 
124,335

 

 
136,543

CASH AND CASH EQUIVALENTS, end of period
$
19,461

 
$
5,422

 
$
77,439

 
$

 
$
102,322